Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 is added and a site-wide notice about government funding, along with the older Revision: v3.4.1, is removed, reflecting minor maintenance updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center status, along with a version update from v3.4.0 to v3.4.1, was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedNew UI elements and external links were added, such as a glossary toggle and a plain-language trial summary reference, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference43%

- Check42 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3; this is a minor site version update with no visible changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section now lists California and Florida sites for the study. The previous 'California Locations' and 'Florida Locations' entries and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.4%

- Check92 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.2 with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.